Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | SYCE2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SYCE2 mRNA | CTD | PMID:22079256 | 1,1-dichloroethene | increases expression | ISO | Syce2 (Mus musculus) | 6480464 | vinylidene chloride results in increased expression of SYCE2 mRNA | CTD | PMID:26682919 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SYCE2 mRNA | CTD | PMID:33387578 | 4-hydroxyphenyl retinamide | increases expression | ISO | Syce2 (Mus musculus) | 6480464 | Fenretinide results in increased expression of SYCE2 mRNA | CTD | PMID:28973697 | acetamide | decreases expression | EXP | | 6480464 | acetamide results in decreased expression of SYCE2 mRNA | CTD | PMID:31881176 | arsane | affects methylation | ISO | SYCE2 (Homo sapiens) | 6480464 | Arsenic affects the methylation of SYCE2 gene | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | SYCE2 (Homo sapiens) | 6480464 | Arsenic affects the methylation of SYCE2 gene | CTD | PMID:25304211 | benzo[a]pyrene | increases methylation | ISO | SYCE2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of SYCE2 promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | ISO | SYCE2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of SYCE2 mRNA | CTD | PMID:32234424 | bis(2-ethylhexyl) phthalate | decreases expression | ISO | SYCE2 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in decreased expression of SYCE2 mRNA | CTD | PMID:31163220 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SYCE2 mRNA | CTD | PMID:25181051 more ... | carbon nanotube | increases expression | ISO | Syce2 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | chlorpyrifos | increases expression | ISO | Syce2 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of SYCE2 mRNA | CTD | PMID:37019170 | coumestrol | increases expression | ISO | SYCE2 (Homo sapiens) | 6480464 | Coumestrol results in increased expression of SYCE2 mRNA | CTD | PMID:19167446 | coumestrol | multiple interactions | ISO | SYCE2 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SYCE2 mRNA | CTD | PMID:19167446 | cyclosporin A | increases expression | ISO | SYCE2 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of SYCE2 mRNA | CTD | PMID:22147139 | decabromodiphenyl ether | affects expression | ISO | SYCE2 (Homo sapiens) | 6480464 | decabromobiphenyl ether affects the expression of SYCE2 mRNA | CTD | PMID:24834073 | dibutyl phthalate | decreases expression | ISO | Syce2 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of SYCE2 mRNA | CTD | PMID:21266533 | dimethyl sulfoxide | affects expression | ISO | SYCE2 (Homo sapiens) | 6480464 | Dimethyl Sulfoxide affects the expression of SYCE2 mRNA | CTD | PMID:24834073 | dioxygen | increases expression | ISO | Syce2 (Mus musculus) | 6480464 | Oxygen deficiency results in increased expression of SYCE2 mRNA | CTD | PMID:20880076 | dorsomorphin | multiple interactions | ISO | SYCE2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Enterolactone | multiple interactions | ISO | SYCE2 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SYCE2 mRNA | CTD | PMID:19167446 | epoxiconazole | increases expression | ISO | Syce2 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of SYCE2 mRNA | CTD | PMID:35436446 | ethyl methanesulfonate | increases expression | ISO | SYCE2 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of SYCE2 mRNA | CTD | PMID:23649840 | ethylparaben | decreases expression | ISO | SYCE2 (Homo sapiens) | 6480464 | ethyl-p-hydroxybenzoate results in decreased expression of SYCE2 mRNA | CTD | PMID:37690743 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of SYCE2 mRNA | CTD | PMID:33387578 | lipopolysaccharide | multiple interactions | ISO | SYCE2 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SYCE2 mRNA | CTD | PMID:35811015 | lipopolysaccharide | decreases expression | ISO | SYCE2 (Homo sapiens) | 6480464 | Lipopolysaccharides results in decreased expression of SYCE2 mRNA | CTD | PMID:35811015 | methyl methanesulfonate | increases expression | ISO | SYCE2 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of SYCE2 mRNA | CTD | PMID:23649840 | methylmercury chloride | decreases expression | ISO | SYCE2 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of SYCE2 mRNA | CTD | PMID:28001369 | ozone | multiple interactions | ISO | Syce2 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SYCE2 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SYCE2 mRNA | CTD | PMID:34911549 | paracetamol | affects expression | ISO | Syce2 (Mus musculus) | 6480464 | Acetaminophen affects the expression of SYCE2 mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of SYCE2 mRNA | CTD | PMID:33387578 | phenylmercury acetate | decreases expression | ISO | SYCE2 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of SYCE2 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | SYCE2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYCE2 mRNA | CTD | PMID:27188386 | pirinixic acid | increases expression | ISO | Syce2 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of SYCE2 mRNA | CTD | PMID:23811191 | potassium chromate | increases expression | ISO | SYCE2 (Homo sapiens) | 6480464 | potassium chromate(VI) results in increased expression of SYCE2 mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | ISO | SYCE2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SYCE2 mRNA | CTD | PMID:22079256 | quercetin | increases expression | ISO | SYCE2 (Homo sapiens) | 6480464 | Quercetin results in increased expression of SYCE2 mRNA | CTD | PMID:21632981 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | SYCE2 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SYCE2 mRNA | CTD | PMID:35811015 | SB 431542 | multiple interactions | ISO | SYCE2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | tetrachloromethane | increases expression | ISO | Syce2 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of SYCE2 mRNA | CTD | PMID:27339419 and PMID:31919559 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of SYCE2 mRNA | CTD | PMID:33387578 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of SYCE2 mRNA | CTD | PMID:34492290 | titanium dioxide | increases expression | ISO | Syce2 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of SYCE2 mRNA | CTD | PMID:23557971 | trichloroethene | increases expression | ISO | Syce2 (Mus musculus) | 6480464 | Trichloroethylene results in increased expression of SYCE2 mRNA | CTD | PMID:25549359 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of SYCE2 mRNA | CTD | PMID:33387578 | trimellitic anhydride | increases expression | ISO | Syce2 (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of SYCE2 mRNA | CTD | PMID:19042947 | triptonide | decreases expression | ISO | Syce2 (Mus musculus) | 6480464 | triptonide results in decreased expression of SYCE2 mRNA | CTD | PMID:33045310 | tungsten | increases expression | ISO | Syce2 (Mus musculus) | 6480464 | Tungsten results in increased expression of SYCE2 mRNA | CTD | PMID:30912803 | valproic acid | decreases expression | ISO | SYCE2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of SYCE2 mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | ISO | SYCE2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYCE2 mRNA | CTD | PMID:27188386 | vancomycin | decreases expression | ISO | Syce2 (Mus musculus) | 6480464 | Vancomycin results in decreased expression of SYCE2 mRNA | CTD | PMID:18930951 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of SYCE2 mRNA | CTD | PMID:23555832 | |